Trial Profile
Study of Ceftolozane/Tazobactam as Outpatient Parenteral Antimicrobial Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Nov 2018
Price :
$35
*
At a glance
- Drugs Ceftolozane/tazobactam (Primary)
- Indications Bacterial infections; Gram-negative infections
- Focus Therapeutic Use
- 13 Nov 2018 New trial record
- 07 Oct 2018 Results presented at the IDWeek 2018